A News

Latest breaking news and updates for A stock.

Track all markets on TradingView

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test ...

How might this approval impact the revenue outlook for both Agilent and Bristol Myers Squibb's immunotherapy products targeting dMMR colorectal cancer? What competitive advantage does this companion diagnostic give Agilent compared to other IHC panel providers and how might it influence market share? How will the FDA approval of Agilent's MMR IHC Panel pharmDx affect Agilent's stock valuation and market sentiment?
Regulatory
about 18 hours ago
Read more businesswire

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

SANTA CLARA, Calif. & ATLANTA--(BUSINESS WIRE)--Agilent Technologies Inc. and Georgia Tech today announced the establishment of an Agilent Center of Excellence (CoE) for Environmental Health and En...

How might this announcement influence analyst sentiment and short‑term trading volume for Agilent's stock? Will the partnership have any impact on Agilent's capital allocation strategy or dividend policy? What risks, if any, are associated with the execution of this collaboration (e.g., project delays, intellectual property disputes, or regulatory hurdles)?
Partnership
8 days ago
Read more businesswire